Asclepius Meditec's Hydrogen Oxygen Generator with Nebulizer is Expected to Alleviate the Oxygen Shortage Crisis during COVID-19 Pandemic
AsiaNet 89317
SHANGHAI, May 1, 2021 /PRNewswire=KYODO JBN/ --
In June, 2020, an academic paper on patients with COVID-19 inhaling hydrogen
oxygen mixed gas produced by Asclepius Meditec's Hydrogen Oxygen Generator with
Nebulizer was published in the Journal of Thoracic Disease. The multicenter,
and open-label clinical trial has also noted that hydrogen oxygen mixed gas
inhalation can improves disease severity and dyspnea in patients with
Coronavirus disease 2019 (DOI: 10.21037/jtd-2020-057).
At the critical moment of the global shortage of ventilators, an innovative
Class III respiratory medical device from China, Hydrogen Oxygen Generator with
Nebulizer, is expected to alleviate the oxygen shortage crisis caused by
another rampage of COVID-19 pandemic.
The design concept of the device is green, environmentally friendly and
creative that the pure water is electrolyzed to produce 3 liters of hydrogen
oxygen mixed gas (H2: 66.6%; O2: 33.3%) for patients with Coronavirus disease
2019 to inhale for therapy.
Hydrogen is the lightest gas in the world and has no toxic effects on humans
(biosafety). Furthermore, the molecular weight of hydrogen-oxygen mixed gas is
extremely small so that it can increase the pulmonary alveoli to intake oxygen
quickly, reduce the airway resistance, and decrease its work of breathing, thus
improving peripheral capillary oxygen saturation (SpO2). Meanwhile, hydrogen
gas has a strong anti-inflammatory ability to prevent the decline of MOF
(Multiple Organ Failure) caused by acute inflammation by the virus. It can be
used for confirmed COVID-19 patients from mild cases, to moderate cases and
severe cases.
Inhalation of hydrogen oxygen mixed gas can alleviate the symptoms of dyspnea,
polypnea, chest distress, chest pain in patients with COVID-19 coronavirus, and
shorten their length of hospitalization, as well. These therapeutic effects of
hydrogen oxygen mixed gas have been reported by Academician Zhong Nanshan and
State Key Laboratory of Respiratory Disease, and concluded in a monograph
officially published by World Scientific Publishing, headquartered in Singapore.
The device can be used alone or in combination of two devices (6 liters of
mixed gas) via a trident joint. It can be also used in parallel with oxygen
pipelines, invasive ventilators and non-invasive ventilators in hospitals.
It is reported that since COVID-19 pandemic, the therapy of hydrogen oxygen
mixed gas has also been included inDiagnosis and Treatment Protocol for Novel
Coronavirus Pneumonia( http://en.nhc.gov.cn/2020-03/29/c_78469.htm ) (Trial
version 7 and 8), and Diagnosis and Treatment Protocol for Severe and Critical
Cases of Novel Coronavirus Pneumonia (Trial version 3), released by China
National Health Commission & State Administration of Traditional Chinese
Medicine.
As of now, Asclepius Meditec has carried out nearly 200 fundamental studies, 18
single-center clinical trial, 8 multi-center clinical trials, and 7 National
Natural Science Foundation projects, as well as published 53 SCI papers and two
monographs Hydrogen Cancer Control, and Hydrogen-Oxygen Inhalation for
Treatment of COVID-19.
Asclepius Meditec's Hydrogen Oxygen Generator with Nebulizer received the
National Innovative Class III medical device certificate by NMPA (Chinese
National Medical Products Administration) in 2020, marking another milestone in
the history of hydrogen-oxygen medicine. Now, the device has passed compliance
tests for medical devices in the EU, including safety, electromagnetic
compatibility, biocompatibility, etc.
Developed for ten years, the technical problem of easy deflagration of hydrogen
oxygen mixed gas is solved by Asclepius Metidec. With the joint efforts of
Asclepius Metidec and global OEM leader Foxconn, the hydrogen oxygen nebulizers
are excellently guaranteed in product quality and service life.
Contact us for Hydrogen Oxygen Generator with Nebulizer:
Tel: +86-21-5990-1777 ext. 1798/1795
E-mail: info@ascleway.com
GLOBAL CONSULTATION TEAM
Benny Lin, +86-13774356437, benny.lin09288@ascleway.com
Leo Gu, +86-13651606401, gufang09045@ascleway.com
No. 758, Jiaxin Road, Malu Town, Jiading District, Shanghai, China
SOURCE: Shanghai Asclepius Meditec
Image Attachments Links:
Link: http://asianetnews.net/view-attachment?attach-id=390458
Caption: Hydrogen Oxygen Generator With Nebulizer(AMS-H-03)
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。